APA (7th ed.) Citation

Neblett II, M. F., Ducharme, M. T., Meridew, J. A., Haak, A. J., Girard, S., Tschumperlin, D. J., & Stewart, E. A. (2025). Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model. Reproductive Sciences, 32(2), 417. https://doi.org/10.1007/s43032-024-01775-6

Chicago Style (17th ed.) Citation

Neblett II, Michael F., Merrick T. Ducharme, Jeffrey A. Meridew, Andrew J. Haak, Sylvie Girard, Daniel J. Tschumperlin, and Elizabeth A. Stewart. "Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model." Reproductive Sciences 32, no. 2 (2025): 417. https://doi.org/10.1007/s43032-024-01775-6.

MLA (9th ed.) Citation

Neblett II, Michael F., et al. "Evaluation of the In Vivo Efficacy of the JAK Inhibitor AZD1480 in Uterine Leiomyomas Using a Patient-derived Xenograft Murine Model." Reproductive Sciences, vol. 32, no. 2, 2025, p. 417, https://doi.org/10.1007/s43032-024-01775-6.